Share Price
follow quotes on
Major Shareholders
Update 31-01-2019
1
2
3
4
5
6
1
François Fornieri 1
28.19%
2
Free Float
33.33%
3
Marc Coucke 2
16.47%
4
Meusinvest SA
14.37%
5
Bart Versluys 3
4.51%
6
Ogesip Invest SA
3.13%
(Shareholdership in accordance with transparency declarations received by the company and notified managers’ transactions)
1 François Fornieri holds warrants entitling him to subscribe 1,023,000 additional shares of Mithra.
2 Marc Coucke holds his shareholding partially through Alychlo NV and Mylecke Management Art & Invest NV, which he both controls.
3 Bart Versluys holds his shareholding through Scorpiaux BVBA, controlled by Bart Versluys.
Voting Rights
Total number of voting rights (denominator)
37,664,245
(all relating to ordinary shares)
Total number of securities carrying voting rights
37,664,245
(all ordinary shares)
Total number of securities carrying voting rights not yet issued
1,047,750
(all related to warrants issued on 2 March 2015 and potentially to be exercised as from 2019)
1,238,339
(all related to warrants issued on 5 November 2018 and potentially to be exercised as from 5 November 2020)
Transparency Declarations
The Articles of the Association of Mithra Pharmaceuticals SA provide for an additional notification threshold of 3% of the total number of existing voting rights.
OGESIP Invest SA
21 November 2017
Bart Versluys
29 December 2016
19 January 2016
François Fornieri
29 June 2018
11 July 2015
Meusinvest SA
29 June 2018
11 July 2015
Marc Coucke Alychlo NV
11 July 2015
OGEO Fund
21 November 2017
11 July 2015
Completed and signed forms should be sent to investorrelations@mithra.com
Analyst Coverage
Degroof Petercam – Stephanie Put
KBC Securities – Sandra Cauwenberghs
Kempen – Alexandru Cogut
Kepler Cheuvreux/Belfius – Thomas Landemaine
Financial Service
The financial service related to transactions involving the Shares of the Company is ensured in Belgium by ING. Should the Company alter its policy in this matter, any change will be announced in the Belgian financial press and on the Company’s website.
